Methods of inhibiting platelet activation and aggregation using peptide vaccine or antibodies that have binding specificity for the β subunit of the (Na++K+)-ATPase are provided, along with methods for inhibiting or preventing thrombosis in a subject using such peptide vaccine or antibodies.